Background: The treatment of Hodgkin's disease (HD) involves irradiation and chemotherapy. Both modalities may cause heart and lung injury. We aimed to assess 1) the occurrence of such injury, 2) the extent to which combined versus single-organ-affection resulted in disability, and 3) whether determinants for cardiopulmonary injury could be identified.
Introduction
Treatment of Hodgkin's disease (HD) involves irradiation and chemotherapy, modalities known to cause both heart and lung injury [I] . Radiation-induced cardiac injury includes pericarditis, coronary artery disease, and valvular and myocardial dysfunction [2] . The two-phased clinical syndrome of radiation pneumonitis and fibrosis has been thoroughly described 131. One of the standard chemotherapy regimens used in HD contains bleomycin and anthracyclines; the former is feared for its pulmonary toxic effects 141 and the latter is cardiotoxic (51. The toxicity of both agents may be enhanced by multi-drug combinations and radiotherapy [6> 71.
We have previously shown that late pulmonary and cardiac sequelae may occur as two separate clinical entities after HD therapy 18, 91. There is reason to believe that combined cardiopulmonary injury may occur ma1 exercise heart rate (P < 0.05). Compared to males, females had an increased risk of heart valve regurgitation (46% versus 16%, P < 0.001), pericardial thickening (22% versus 1O0/0, P = 0.07) and reduced gas transfer (41% versus 22%, P = 0.03). Female gender was a significant risk factor for cardiac and/or pulmonary sequelae (OR 6.1,95% CI 2.4 in some of the patients. Distinguishing between cardiac and pulmonary causes of impaired function in HD patients can be problematic. Studies evaluating both cardiac and pulmonary function in the same patient population could solve this problem, but most of the few such studies which have been undertaken [lo-151 have been limited by their low accruals (<50 patients) (10, (12) (13) (14) . To the best of our knowledge, long-term cardiac and pulmonary evaluation has not previously been investigated jointly in any large single-center study.
Based on a study comprising a national cohort of 116 long-term HD survivors, we asked the following questions: 1) How frequently does cardiac and pulmonary sequelae occur jointly after I-ID therapy? 2) Does combined cardiopulmonary affection result in a greater extent of disability and physical dysfunction than separate instances of cardiac and pulmonary impairment? and 3) Are there any determinants for cardiopulmonary injury?
Material and methods

Study population
bulky mediastinal disease had received induction chemotherapy before radiation and in no case had a mediastinal b m s t dose been given.
Before 1988 all treatment of HD in Norway was performed in a single center, the Norwegian Radium Hospital. In January 1993 we reviewed the files of all 427 consecutive patients (national cohort) who had been treated for biopsy-proven HD during the period 1980-88, and found that 282 (66%) of them were still alive. We limited the study to patients who fulfilled the following criteria: 1) treatment with standardized mediastinal radiation alone or combined with chemotherapy, 2) age under 50 years at the time of diagnosis and 3) in complete remission for more than five years at the time of follow-up. Of the 129 eligible patients, 13 were lost to follow-up. l h o did not reply to the invitation, five failed to attend due to inconvenience (work, school) and six did not wish to specify why they declined the invitation. The patients lost to follow-up were comparable to the study group with respect to gender (8 males and 5 females), median age (36 and 3 9 years) and median period of observation (10 years). The remaining 116/129 patients (900/0) were enrolled in the study after giving their signed informed consent. The study was approved by the Regional Ethics Committee.
In all patients, histologic subtyping had been performed according to the Rye classification (161 and clinical staging according to the Ann Arbor classification [17] . Bulky mediastinal disease was defined as tumor mass > 6 cm in diameter by radiologic examination, or mediastinal widening of more than 1/3 of the widest thoracic diameter. Distribution of histologic types, clinical stages and bulky mediastinal disease according to gender is presented in Table 1 . Nodular sclerosis occurred nearly twice as frequently in females as in males (75% versus 43O/0), while lymphocytic predominance occurred almost exclusively in males. The two genders were comparable with respect to distribution of clinical stages and bulky mediastinal disease.
All patients had received radiotherapy. Forty of them (stages IA and IIA) had received no further treatment, whereas the remaining 76 (42 males and 34 females) had received additional chemotherapy. In all cases chemotherapy had been administered before the radiation except in 14 patients who had relapsed after initial radiotherapy and therefore required chemotherapy. All patients with 
Clinical and radiographic evaluation
At follow-up the patients' medical records were reviewed, with special attention to the occurrence of cardiovascular and pulmonary diseases prior to HD therapy. All patients underwent a structured clinical inteniew and a physical examination. Questions included status of occupation and employment (particular notes was taken of patients receiving disability benefits or pensions), occurrence of lung and heart disease (including rheumatic fever) and use of longterm medication prior to and after HD therapy. To categorize smoking habits, the patients were classified as Life-long non-smokers, ex-smokers or current smokers. Ex-smokers were those who had stopped smoking at least one year before the study. Symptoms and signs of cardiac and pulmonary disease were registered. The patients were functionally categorized according to the New York Heart Association (NYHA) classi6cation 1231. Haematologic tests included hemoglobin, erythrocyte sedimentation rate, white cell count and plasma lipids. Chest X-rays were taken and viewed in a blinded manner by two independent observers. Fibrotic manifesta-tions were classified according to Jensen et al. 1241 as 'none, slight, moderate or severe' as previously described [8] . Relative heart volume (mVm2 M y surface area) was calculated according to the standard formula 1251.
A Vigmed CFM 700 or 750 ultrasound device (Vingmed Sound, Hortcn, Norway) with a Duplex mechanical annular array probe was used. The probe applied the frequency 3.25 MHz for imaging tissue and 2.5 MHz for the Doppler studies.
The patients were examined in the lateral recumbent position after 15-minutes of rest. The heart was visualized using standard ultrasonic techniques and acoustic windows. Dimensions were determined by M-mode echocardiography or twodimensional technique when appropriate. Measured and calculated variables of cardiac function were: left ventricular end-systolic (LVESD) and enddiastolic (LVEDD) diameters, left ventricular shortening fraction (LV-SF), left atrial diameter, thickness of interventricular septum and left ventricular posterior wall, the ratio between peak early (E) and atrial (A) transmital flow velocities (E/A ratio), deceleration time of E velocity, and cardiac index Pulsed, continuous and color Doppler echocardiography in at least three planes was used for exploring valvular function. Valvular regurgitations were quantitated on a 0-3 scale (0 -none, 1 -small, 2 -moderate, 3 -severe) according to described criteria [26, 27] . We defined valvular regurgitation greater than grade 1 as abnormal. Abnormal pericardium was diagnosed as described by Feigenbaum 1281.
Normal values for cardiac dimensions and blood flow were defined according to reference material on healthy Norwegians adults 1291. We used a reference group of 40 healthy subjects (20 males, 20 females, mean age 40 f 11 (SD) years for the Doppler studies.
Exercise testing
All patients performed a symptom-limited incremental exercise test on a stationary, electrically braked cycle ergometer (ErgoMetrics 900, Jaeger, Germany). The initial workload was 50 watts. Increments of 50 watts were added every 4 minutes. The patients were instructed to maintain a pedal frequency of 60 rev/min, and were encouraged to exercise to the point of exhaustion. Blood pressure (BP) was recorded by auscultation and heart rate (HR) by a continuous standard 12-lead electrocardiogram (ECG), at rest in the supine position, at the end of each exercise step and every 2 minutes during the post-exercise recovery period. Reference values for exercise capacity, maximum HR and systolic BP were those of Nordenfelt et al. [301. Pathological S-T segment depression was defined as previously described [31] . Exercise-induced hypoxemia was assessed by a pulse oximeter (Minolta Pulsox-7, Devilbiss). Oxygen saturation (SaO,) was monitored continuously by a flexible finger probe. Baseline SaO, was recorded during a five-minute period (while sitting on the bicycle) before start of the exercise test. The minimum SaO, was defined as the lowest SaO, value sustained for more than 10 seconds during exercise. A decline in SaO, of 4% or more was considered significant desaturation.
Lung function
All measurements were performed with the Gould automated system 2400 (Sensormedin BV, Bilthoven, The Netherlands) and according to the guidelines recommended by the American Thoracic Society 132, 331. Spirometric variables included forced vital capacity (FVC), forced expiratory volume in 1 second (FEV,) and FEV, expressed as percent of FVC (FECI0b). Total lung capacity (TLC) and its subdivisions were calculated fmm measurements of the functional residual capacity (FRC) performed by the multibreath helium equilibration method. Carbon-monoxide diffusing capacity @LCO) was measured by the single breath technique and the alveolar volume (VA) was calculated by helium dilution while the breath was held. The transfer coefficient (KCO) was calculated as DLCOlVA. The variables were expressed in absolute values and as a percentage of predicted normal values. Reference values were those recommended by the European Respiratory Society (ERS) (34, 351 . Restrictive ventilatory impairment was defined as TLC and FVC less than 80% of predicted normal values, which correspond to the lower 5th percentiles of the recommended summary equations for lung volumes 1341. Obstructive impairment was defined as FEV, less than 80% of predicted and FEV,% less than 70% 1361. Impairment of gas diffusing capacity was defined as DLCO less than 800/0 of predicted value, which corresponds to the lower 5th percentile for DLCO in the reference material recommended by the ERS 135).
Classification of patients
The patients were classified by four categories of sequelae: 1) Pulmonary sequelae (restrictive, obstructive or reduced gas diffusing capacity), 2) cardiac sequelae (coronary artery disease, pencardial thickening or valvular dysfunction), 3) cardiopulmonary sequelae (the presence of both 1) and 2) in the same patient), and 4) nil sequelae (no evidence of either 1) or 2)).
Statistics
All calculations were performed with the SPSSRC statistical computing package 1371. Categorical data were compared by the Chisquare test. Group mean data were compared by a two-tailed unpaired Student's t-test or one-way analysis of variance when appropriate. Scheffe's correction for the level of si@cance was used when more than two comparisons were camed out. Multiple linear regression analysis was used to detect relationships between echocardiographic parameters of myocardial function and relevant independent covariates. Associations between cardiopulmonary sequelae and selected risk factors were estimated by multiple logistic regression analyses. The four categories of sequelae were transformed into a binary variable, 0 -no sequelae and 1 -cardiac and/ or pulmonary sequelae. Histological types were tested as nodular sclerosis w m the other types. Current smokers and ex-smokers were tested wrsus non-smokers. Total radiation dose was entered as a continuous variable, whereas fractional dose was tested as a binary variable (0 -1.8 Gy and 1 -2.0 Gy). The independent variables entered into the regression m d e l s were those that were hypothesized a priori for biological or clinical reasons, or found to be significant at the 25% level by previous univariate analyses.
Results
The clinical characteristics of the patients are outlined in Tables 2 and 3 . Cardiovascular disease (including rheumatic fever), cardiac murmurs or other signs of cardiac disorder had not been registered in any of the patients prior to HD therapy. Five patients had histories of mild childhood asthma. Otherwise there were no cases of previous pulmonary disease. None of the patients had ever been treated with thoracotomy, and none had received chest irradiation or potentially heart lung-toxic drugs before they started HD treatment.
Cardiac, pulmonary or combined cardiopulmonary sequelae were detected in 56% of the patients, affecting 75% of the females versus 41% of the males (P < 0.001). Of the patients with cardiopulmonary sequelae 27% received disability benefits/pensions, whereas only 4% of the remaining patients did so (P < 0.05). ' P < 0.05 versus 'other categories'.
Meanf SD.
Cardpulm -cardiopulmonary; Card -cardiac; Pulm -pulmonary. The reasons for receiving disability benefits were related to the cardiopulmonary impairment in all but one case (psychiatric disease). The four categories were comparable with respect to age, duration of follow-up and the registered risk factors for cardiopulrnonary disease (smoking habits, overweight, hypothyroidism and blood lipids). No patients had received heart-lung toxic drugs other than those included in the HD regimens.
With respect to clinical characteristics, patients who had received chemotherapy did not differ sigd3cantly from those who had received radiation only. The 30 cases of bulky mediastinal disease were evenly distributed among the four categories of sequelae. The four categories did not differ with respect to mean radiation dose or fractionation. Fibrotic manifestations (slight and moderate) and dyspnoea on exertion were significantly associated with cardiopulmonary sequelae ( P < 0.05 and P < 0.001, respectively), but not with irnpaired pulmonary function only (Table 3) . Relative heart volume was within the normal range (150-450 ml/m2) in d patients. Mean values for body mass index, hemoglobin and plasma lipids did not differ significantly among the four categories. Males and females differed signt£icantly with respect to the occurrence of valvular regurgitation and gas transfer impairment, but not with respect to pericardial thickening, coronary artery disease, restrictive and obstructive ventilatory impairment (Table 4) . In 20 females, 22 valves with left-sided regurgitation were recorded (11 aortic, 7 rnitral and 2 combined aortic and rnitral). Two of the females with aortic regurgitation also had coronary artery disease (one of them required surgical treatment with concomitant aortic valve replacement and coronary artery bypass grafhng). Pericardial thickening was present in 11 females, two of whom also had left-sided regurgitations. In 11 males, 11 valves with regurgitation were recorded (8 aortic and 3 rnitral). Of the seven males with pericardial thickening, two had left-sided regurgitations. Of the four males with coronary artery disease, one had concomitant rnitral regurgitation and one had pericardial thickening. No subject in the reference group had abnormal valvular regurgitation. We found no doseresponse effect of radiation dose or fractionation on either cardiac or pulmonary pathology.
In addition to having reduced ventilatory function, the patients with cardiopulmonary impairment had significantly reduced DLCO compared to patients with pulmonary impairment only (DLCO 68% versus 75% of predicted, P -0.03).
Patients with cardiac sequelae had higher resting HR Mean measured and calculated indices of systolic and diastolic function were within the reference values for all four categories, with no sigmficant differences among them. LV-SF was below the lower range of the predicted value in 13 (11%) patients (range LV-SF 22O/r28O/o), indicating reduced contractility. LVEDD and LVESD were not increased in any of the patients. Of the 13 patients with reduced LV-SF, three had coronary artery disease, two had valvular regurgitation and two had pericardial thickening. The E/A ratio was below 0.8 in four patients with pericardial thickening, suggesting impaired diastolic function. When we malysed the effect of the cumulative dose of doxorubicin on indices of myocardial function in a multiple linear regression model (controlling for sex, age, body surface area and years of follow-up), no sigmlicant doseresponse effect was found. Myocardial dysfunction was not significantly associated with impaired pulmonary function.
Compared to those with normal valvular function, patients with aortic regurgitation had signdicantly reduced DLCO and KC0 (89% versus 78%, and 76% versus 69% of predicted, respectively, P < 0.05) and patients with rnitral regurgitation and reduced FEV, (96% versw 83% of predicted, P< 0.05).
Controlling for age, gender, duration of follow-up, histology, bulky mediastinal disease, treatment modality and doses of radiation in a logistic regression model, we found that female gender was sigdicantly associat- HR -hean rate; BP -blood p m r e ; SaO, -oxygen saturation Other abbreviations as in legend to Table 2 .
ed with cardiac and/or pulmonary sequelae (OR 6.1, 95% CI 2.4-15.7) ( Table 6 ).
Discussion
The major hndings of this study were that 1) more than half of the patients had cardiac and/or pulmonary sequelae and in one-third of them both organs were affected, 2) patients with combined organ injury were characterized by a larger degree of physical dysfunction than patients with single-organ affection and 3) the risk of cardiac and cardiopulmonary injury appeared to be increased in females. The high prevalence of cardiac and pulmonary sequelae in our study group could not be explained by factors unrelated to the HD therapy. Cardiovascular disease (including rheumatic fever and cardiac murmurs) had not been diagnosed in any of the patients prior to HD treatment, and no cases of chronic lung disease had been recorded (apart from seven patients with mild childhood asthma). Drugs with potential heart-lung toxicity other than those included in the HD regimens had not been used by any of them. The patients' smoking habits and levels of plasma lipids corresponded to those of the general population [38, 391.
As a group the patients with both cardiac and pulmonary sequelae demonstrated a larger degree of physical dysfunction than the other patients. Nearly 30% of them received disability pensions, and 60% reported dyspnoea on exertion. None of them had been disabled prior to HD therapy, and none recalled previous limitations in physical activity due to breathlessness. Although their bicycle exercise capacity was within normal limits, they reached a lower maximal exercise HR than the rest of the patients. In contrast, patients with isolated cardiac or pulmonary sequelae were functionally comparable to those with no signs of injury.
No extra-cardiopulmonary factors could explain why the group with combined organ affection should demonstrate a larger degree of disability and physical Assessed by echocardiography, we detected valvular and/or pericardial pathology in one-third of the patients, while myocardial function appeared to be well preserved. The latter may seem surprising, since myocardial damage may be induced by both radiation and chemotherapy, whereas valvular and pericardial lesions are thought to be caused by radiation per se. Part of the explanation may be methodological limitations. While echocardiography is a sensitive and reliable non-invasive method for evaluating left ventricular function, it is of limited use in assessing the function of the right ventricle. With standard mantle field technique the right ventricle is usually exposed to the entire radiation dose, whereas considerable parts of the left ventricle will be spared. Furthermore, subclinical myocardial abnormalities may not be manifest at rest and would therefore not have been detected by standard echocardiographic examination. Thus, we may speculate that some of the exercise-induced symptoms reported by our patients may partly have been manifestations of right ventricular dysfunction.
Aortic and rnitral valvular regurgitations were diagnosed in one-fourth of our patients. Compared with our own reference group and with another reference material (401, both the proportion and severity of regurgitations were outside the normal physiological range. These findings are in contrast to the general assumption that heart valve injury is a rare sequelae after mediastinal radiation. However, as this assurnption partially reflects the diagnostic limitations of 'old' non-invasive methods, it has been challenged, also by previous studies [13, 411 that have employed modem Doppler ultrasound technique, which, by today's standards, is considered the only sensitive and reliable noninvasive method for studying heart valve function. This method has been available for clinical use since the mid 1980s, but, to our knowledge, it has been employed in only two previous long-term studies of I-ID survivors treated with highdose radiation [13, 411. Those studies, like ours, both reported a high prevalence of leftsided valvular regurgitations, which were diagnosed in, respectively, 40% and 15% of the two study populations. In the latter series, which involved a wide range of doses, no valvular lesions were observed in patients who had received 30 Gy or less. The predominance of left-sided regurgitations seen in irradiated patients is in contrast to that observed in healthy subjects [40, 42, 431 , but in accordance with reports on severe radiationassociated valvular disease [44-461. Of the cases reported up until 1991, left-sided lesions comprised 93%, and the review article describes a continuum of valvular disease following radiation that begins with mild asymptomatic lesions and progresses to severe valvular incompetence [44] . Since radiation doses varied only within a very narrow range (40-42 Gy) in our study, we obviously could not find a dose-response effect on the occurrence of valvular lesions, nor could we expect to find an association between bulky mediastinal disease and cardiac injury, since no boost radiation had been given to the mediastinum. All patients with bulky mediastinal disease had been treated with pre-radiation chemotherapy in order to reduce the radiation volume, and an additional mediastinal boost to residual disease had not been given to any of the patients.
Assessment of both cardiac and pulmonary function in the same patient population has been reported in only a few previous studies, and their results have been in conflict [lo-151. In a study that included 25 patients, Morgan et al. [lo] found minor reductions in lung function in 89% and abnormal ventricular function in 24% of the patients. Watchie et al. [ll] reported minimal cardiopulmonary dysfunction in one-third of the patients 1-15 years after therapy. Their material was, however, highly selected, in that patients with major risk factors (smoking and treatment with adriamycin-bleomycin) had been excluded. Brice et al. [I21 found lung function reductions in 20%-40% of the patients, while cardiac dysfunction was minimal. Exercise testing was not performed in that study, and the observation period was only six months to three years. AUavena et al. [15] reported minimal cardiopulmonary dysfunction 3-10 years after mantle irradiation with or without chemotherapy. Gustavsson et al. [13] found serious cardiac sequelae in 15% of the patients and minor abnormalities in nearly 50%. In a separate publication they reported minor reductions in pulmonary function in the same study population that included 25 patients [14] . These studies all comprised small numbers of patients (from 25 to 75). None of them employed modem three-mode Doppler echocardiography. A U reported the occurrence of cardiac and pulmonary dysfunction separately, and did not attempt to specifically identify and assess patients with combined injury. Potential differences between the genders were not addressed in any of these studies.
We found that females had an increased risk of cardiac and cardiopulmonary sequelae. Pathological leftsided valvular regurgitations were present in nearly one-half of the females in our study group as compared to in 16% of the males. No similar difference between the genders has been observed in prevalence studies of valvular regurgitation in healthy subjects [40, 42, 431. In contrast, selected angiographic materials, reporting radiation-induced coronary and valvular disease, have shown a female preponderance [45, 461. Of the 35 cases of radiation-associated valvular disease reported before 1991, 23 (66%) were females [44] . The two echo-Doppler studies of HD survivors previously referred to [13, 41] presented no data on male: female ratios.
We do not know why gender should be an important prognostic factor for developing HD-treatment-related cardiac injuries, with females being more affected. Males and females were comparable with respect to baseline clinical characteristics and risk factors, bulky mediastinal disease was evenly distributed between the genders, and males and females did not differ si@-cantly with respect to total radiation dose or fractionation. At follow-up all port films were reviewed, but it is not possible retrospectively to give a reliable estimate of the irradiated cardiac volume, since the films may have been taken in either diastole or systole. However, since the average cardiac volume is smaller in females than in males, it is possible that a larger portion of the heart may have been treated in the female patients. This portion would involve parts of the left ventricle, but it would not affect the cardiac structures located centrally in the mediastinum. This implies that a potential difference in left ventricular function between the genders might be explained by differences in irradiated cardiac volume, but the observed difference between the genders with respect to left-sided valvular lesions requires different explanations. We are aware that more information on dose-complication relationships is required and that our results need confirmation by others. However, our observations seem to add to the list of recent studies suggesting that females may indeed be more vulnerable to adverse effects of anti-cancer therapy than males [47-501.
Neither age nor number of years since treatment appeared to influence the risk of developing cardiac and/ or pulmonary sequelae. Chemotherapy, with or without anthracyclines, did not increase the risk of systolic and diastolic myocardial dysfunction. This is most likely because the median cumulative dose of anthracyclines was kept well below the recommended threshold dose [5] . Although the median cumulative dose of bleomycin was also kept far below the recommended threshold [4], we previously found that regimens containing bleomycin were associated with lung function reductions PI-
In conclusion, although signs of cardiac and/or pulmonary injury can be detected in more than 5Ooh of long-term HD survivors, only patients with combined injury seem to be characterized by a high degree of disability, the presence of symtoms and a reduction in physical performance capacity. Females appear to have an increased risk of developing cardiac and cardiopulmonary sequelae, and although these observations need confirmation by others, it would seem prudent to k u them in mind when new routines for long-term follow-up procedures are being established.
